InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LTA-SA | Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteich... | 2022 | Respir Res. | Pereverzeva L. et al. | DOI: 10.1186/s12931-022-02168-6 |
THP1-Dual™ Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
2'3'-cGAMP | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
THP1-Dual™ KO-STING Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
Zeocin® | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
Blasticidin | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
THP1-Dual™ KO-TREX1 Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
c-di-AMP VacciGrade™ | Gut microbiota modulate radiotherapy-associated antitumor immune responses ag... | 2022 | Gut Microbes | Li Z. et al. | DOI: 10.1080/19490976.2022.2119055 |
MDP | C/EBPβ Promotes LPS-Induced IL-1β Transcription and Secretion in Alveolar Mac... | 2022 | J Inflamm Res. | Luo Y. et al. | DOI: 10.2147/JIR.S377499 |
Plasmocin® - Mycoplasma Elimination Reagent | Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... | 2022 | Metabolites | Maillard M. et al. | DOI: 10.3390/metabo12090852 |
Poly(I:C) (HMW) VacciGrade™ | Differences in acute phase response to bacterial, fungal and viral antigens i... | 2022 | Sci Rep. | Seltmann A. et al. | DOI: 10.1038/s41598-022-18240-6 |
Zymosan | Differences in acute phase response to bacterial, fungal and viral antigens i... | 2022 | Sci Rep. | Seltmann A. et al. | DOI: 10.1038/s41598-022-18240-6 |
Plasmocin® - Mycoplasma Elimination Reagent | Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... | 2022 | Metabolites | Maillard M. et al. | DOI: 10.3390/metabo12090852 |
LL-37 | Human Cytomegalovirus Induces Vitamin-D Resistance In Vitro by Dysregulating ... | 2022 | Viruses | Stecher C. et al. | DOI: 10.3390/v14092004 |
Recombinant human IL-1β protein (E. coli) - Bioactive cytokine | Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fi... | 2022 | J Periodontal Res. | Abidi A.H. et al. | DOI: 10.1111/jre.13050 |
R848 (Resiquimod) | Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is require... | 2022 | Cell Discov. | Yao Y. et al. | DOI: 10.1038/s41421-022-00453-8 |
Zeocin® | Targeted immunotherapy against distinct cancer-associated fibroblasts overcom... | 2022 | Nat Commun. | Rivas E.I. et al. | DOI: 10.1038/s41467-022-32782-3 |
Puromycin | Targeted immunotherapy against distinct cancer-associated fibroblasts overcom... | 2022 | Nat Commun. | Rivas E.I. et al. | DOI: 10.1038/s41467-022-32782-3 |
Primocin® | Establishment of a human 3D pancreatic adenocarcinoma model based on a patien... | 2022 | Transl Res. | Sensi F. et al. | DOI: 10.1016/j.trsl.2022.08.015 |
Alhydrogel® adjuvant 2% | Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Adminis... | 2022 | Pharmaceuticals (Basel) | Vo T.P. et al. | DOI: 10.3390/ph15091128 |